{
  "ticker": "EMR",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02967906",
  "id": "02967906",
  "pages": 8,
  "price_sensitive": false,
  "date": "20250709",
  "time": "1825",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250709/pdf/06ln7fbyryvxlm.pdf",
  "summary": "**Key Material Information (Appendix 2A - Securities Quotation):**  \n- **Total new ordinary shares issued:** 1,275,000 (EMR) on 09/07/2025 via options conversion:  \n  - 175,000 shares from EMRAK options (exercise price: $1.09).  \n  - 1,100,000 shares from EMRAE options (exercise price: $0.67), including 1,000,000 by KMP Michael Evans.  \n- **Post-issuance issued capital:** 658,865,123 ordinary shares (EMR).  \n- **Outstanding unquoted options:** Details provided (e.g., EMRAE: 925,000 remaining at $0.67 expiry 30-Jul-2025).  \n\n*Note: No material impact on capital structure or liquidity noted beyond standard dilution from options exercise.*",
  "usage": {
    "prompt_tokens": 2743,
    "completion_tokens": 188,
    "total_tokens": 2931,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-09T09:23:43.498336"
}